NCT04349267 2025-12-17Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid TumorsBristol-Myers SquibbPhase 1/2 Completed44 enrolled 22 charts
NCT03693612 2024-08-28GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsGlaxoSmithKlinePhase 1/2 Completed26 enrolled 47 charts
NCT02599324 2023-11-18Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary TumorsPharmacyclics LLC.Phase 1/2 Completed263 enrolled 34 charts